Jasmin Tiro is a Professor in the Department of Public Health Sciences and Associate Director of Cancer Prevention and Population Science for the University of Chicago Medicine Comprehensive Cancer Center. She is a behavioral scientist focused in cancer care delivery research. Her program of research identifies multi-level determinants of cancer prevention and early detection behaviors (e.g., HPV vaccination; breast, cervical, and colorectal cancer screening; hepatocellular cancer surveillance) and uses quantitative and qualitative (mixed) methods to develop, test, and implement interventions. The availability of screening tests to detect breast, cervical, and colorectal cancer early and the HPV vaccine to prevent HPV-related cancers are great public health accomplishments; however, there are segments of the population that still do not receive the full benefits of these behaviors. All of these health behaviors require individuals to interact with health care provider teams and systems. Effective interventions must take into account the local community and policy context and must be easy to implement and sustain. Further, as new technologies (e.g., home-based HPV self-screening) prove effective and are incorporated into clinical guidelines, the need for appropriate and effective communications to transfer knowledge from “bench to bedside” will be even greater in order to maximize the potential of these new technologies in reducing cancer morbidity and mortality. Dr. Tiro's research is at the interface of intervention and implementation science, requires engagement of diverse communities, and is dedicated to promoting equity in cancer outcomes.
University of Texas School of Public Health
Houston, Texas
PhD - Behavioral Sciences
2005
Emory University- Rollins School of Public Health
Atlanta, Georgia
MPH - Behavioral Sciences & Health Education
1999
Rice University
Houston, Texas
BA - Biochemistry
1997
Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019.
Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019. Cancer Causes Control. 2024 Nov 13.
PMID: 39537980
Exploring adolescent contraceptive counseling: A hypothetical daughter scenario.
Exploring adolescent contraceptive counseling: A hypothetical daughter scenario. Patient Educ Couns. 2025 Jan; 130:108486.
PMID: 39504803
Historical Bias in Mortgage Lending, Redlining, and Implications for the Uncertain Geographic Context Problem: A Study of Structural Housing Discrimination in Dallas and Boston.
Historical Bias in Mortgage Lending, Redlining, and Implications for the Uncertain Geographic Context Problem: A Study of Structural Housing Discrimination in Dallas and Boston. J Urban Health. 2024 Oct; 101(5):1037-1044.
PMID: 39168963
Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results.
Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results. J Gen Intern Med. 2024 Dec; 39(16):3217-3224.
PMID: 39060782
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings. Cancer Epidemiol Biomarkers Prev. 2024 Jul 01; 33(7):912-922.
PMID: 38652505
Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems.
Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems. Prev Med Rep. 2024 Jul; 43:102783.
PMID: 38883925
Confidence in adolescent contraceptive counseling among residents and fellows training at the University of Texas Southwestern in Dallas, Texas.
Confidence in adolescent contraceptive counseling among residents and fellows training at the University of Texas Southwestern in Dallas, Texas. Contraception. 2024 Sep; 137:110478.
PMID: 38705505
Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix. LGBT Health. 2024 Oct; 11(7):563-569.
PMID: 38648535
Community Outreach and Engagement at U.S. Cancer Centers: Notes from the Third Cancer Center Community Impact Forum.
Community Outreach and Engagement at U.S. Cancer Centers: Notes from the Third Cancer Center Community Impact Forum. Cancer Epidemiol Biomarkers Prev. 2023 12 01; 32(12):1777-1782.
PMID: 37791915
Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial. JAMA. 2023 11 28; 330(20):1971-1981.
PMID: 38015219
Bill Aston Award for Quality
Texas Hospital Association
2017
Outstanding Mentorship Award
University of Texas Southwestern, Center for Translational Medicine
2014
Cancer Prevention Research Training Merit Award
National Cancer Institute
2007
Fellows Award for Research Excellence
National Institutes of Health
2006
AACR/ACS Scholarship for Behavioral Scientists
American Association for Cancer Research & American Cancer Society
2006
Dr. Ronald Lorimor Scholarship
University of Texas
2004
Dr. Lawrence E. Lamb Scholarship
University of Texas
2002
Delta Omega National Public Health Honor Society
Emory Rollins School of Public Health
1999